Emily G McDonald1,2,3, Nandini Dendukuri4, Charles Frenette2,3, Todd C Lee1,2,3,4. 1. Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada. 2. Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Québec, Canada. 3. McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, Québec, Canada. 4. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
Abstract
IMPORTANCE: Health care-associated infections are often caused by multidrug-resistant organisms and substantially factor into hospital costs and avoidable iatrogenic harm. Although it is recommended that new facilities be built with single-room, low-acuity beds, this process is costly and evidence of reductions in health care-associated infections is weak. OBJECTIVE: To examine whether single-patient rooms are associated with decreased rates of common multidrug-resistant organism transmissions and health care-associated infections. DESIGN, SETTING, AND PARTICIPANTS: A time-series analysis comparing institution-level rates of new multidrug-resistant organism colonization and health care-associated infections before (January 1, 2013-March 31, 2015) and after (April 1, 2015-March 31, 2018) the move to the hospital with 100% single-patient rooms. In the largest hospital move in Canadian history, inpatients in an older, tertiary care, 417-bed hospital in Montréal, Canada, that consisted of mainly mixed 3- and 4-person ward-type rooms were moved to a new 350-bed facility with all private rooms. EXPOSURES: A synchronized move of all patients on April 26, 2015, to a new hospital with 100% single-patient rooms equipped with individual toilets and showers and easy access to sinks for hand washing. MAIN OUTCOMES AND MEASURES: Rates of nosocomial vancomycin-resistant Enterococcus (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) colonization, VRE and MRSA infection, and Clostridioides difficile (formerly known as Clostridium difficile) infection (CDI) per 10 000 patient-days. RESULTS: Compared with the 27 months before, during the 36 months after the hospital move, an immediate and sustained reduction in nosocomial VRE colonization (from 766 to 209 colonizations; incidence rate ratio [IRR], 0.25; 95% CI, 0.19-0.34) and MRSA colonization (from 129 to 112 colonizations; IRR, 0.57; 95% CI, 0.33-0.96) was noted, as well as VRE infection (from 55 to 14 infections; IRR, 0.30, 95% CI, 0.12-0.75). Rates of CDI (from 236 to 223 infections; IRR, 0.95; 95% CI, 0.51-1.76) and MRSA infection (from 27 to 37 infections; IRR, 0.89, 95% CI, 0.34-2.29) did not decrease. CONCLUSION AND RELEVANCE: The move to a new hospital with exclusively single-patient rooms appeared to be associated with a sustained decrease in the rates of new MRSA and VRE colonization and VRE infection; however, the move was not associated with a reduction in CDI or MRSA infection. These findings may have important implications for the role of hospital construction in facilitating infection control.
IMPORTANCE: Health care-associated infections are often caused by multidrug-resistant organisms and substantially factor into hospital costs and avoidable iatrogenic harm. Although it is recommended that new facilities be built with single-room, low-acuity beds, this process is costly and evidence of reductions in health care-associated infections is weak. OBJECTIVE: To examine whether single-patient rooms are associated with decreased rates of common multidrug-resistant organism transmissions and health care-associated infections. DESIGN, SETTING, AND PARTICIPANTS: A time-series analysis comparing institution-level rates of new multidrug-resistant organism colonization and health care-associated infections before (January 1, 2013-March 31, 2015) and after (April 1, 2015-March 31, 2018) the move to the hospital with 100% single-patient rooms. In the largest hospital move in Canadian history, inpatients in an older, tertiary care, 417-bed hospital in Montréal, Canada, that consisted of mainly mixed 3- and 4-person ward-type rooms were moved to a new 350-bed facility with all private rooms. EXPOSURES: A synchronized move of all patients on April 26, 2015, to a new hospital with 100% single-patient rooms equipped with individual toilets and showers and easy access to sinks for hand washing. MAIN OUTCOMES AND MEASURES: Rates of nosocomial vancomycin-resistant Enterococcus (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) colonization, VRE and MRSA infection, and Clostridioides difficile (formerly known as Clostridium difficile) infection (CDI) per 10 000 patient-days. RESULTS: Compared with the 27 months before, during the 36 months after the hospital move, an immediate and sustained reduction in nosocomial VRE colonization (from 766 to 209 colonizations; incidence rate ratio [IRR], 0.25; 95% CI, 0.19-0.34) and MRSA colonization (from 129 to 112 colonizations; IRR, 0.57; 95% CI, 0.33-0.96) was noted, as well as VRE infection (from 55 to 14 infections; IRR, 0.30, 95% CI, 0.12-0.75). Rates of CDI (from 236 to 223 infections; IRR, 0.95; 95% CI, 0.51-1.76) and MRSA infection (from 27 to 37 infections; IRR, 0.89, 95% CI, 0.34-2.29) did not decrease. CONCLUSION AND RELEVANCE: The move to a new hospital with exclusively single-patient rooms appeared to be associated with a sustained decrease in the rates of new MRSA and VRE colonization and VRE infection; however, the move was not associated with a reduction in CDI or MRSA infection. These findings may have important implications for the role of hospital construction in facilitating infection control.
Authors: Guillaume Butler-Laporte; Matthew P Cheng; Daniel J G Thirion; Samuel De L'Étoile-Morel; Charles Frenette; Katryn Paquette; Alexander Lawandi; Emily G McDonald; Todd C Lee Journal: Open Forum Infect Dis Date: 2020-09-24 Impact factor: 3.835
Authors: Margreet C Vos; Anne F Voor In 't Holt; Adriënne S van der Schoor; Juliëtte A Severin; Anna S van der Weg; Nikolaos Strepis; Corné H W Klaassen; Johannes P C van den Akker; Marco J Bruno; Johanna M Hendriks Journal: Antimicrob Resist Infect Control Date: 2022-06-02 Impact factor: 6.454
Authors: Emanuela Estera Boncea; Paul Expert; Kate Honeyford; Anne Kinderlerer; Colin Mitchell; Graham S Cooke; Luca Mercuri; Céire E Costelloe Journal: BMJ Qual Saf Date: 2021-01-25 Impact factor: 7.035
Authors: Cinzia Ullrich; Anne M Luescher; Robert N Grass; Hugo Sax; Julian Koch Journal: Antimicrob Resist Infect Control Date: 2022-01-10 Impact factor: 4.887
Authors: Lena M Biehl; Paul G Higgins; Jannik Stemler; Meyke Gilles; Silke Peter; Daniela Dörfel; Wichard Vogel; Winfried V Kern; Hanna Gölz; Hartmut Bertz; Holger Rohde; Eva-Maria Klupp; Philippe Schafhausen; Jon Salmanton-García; Melanie Stecher; Julia Wille; Blasius Liss; Kyriaki Xanthopoulou; Janine Zweigner; Harald Seifert; Maria J G T Vehreschild Journal: Euro Surveill Date: 2022-01
Authors: Andrés Pérez-López; Sathyavathi Sundararaju; Kin Ming Tsui; Hassan Al-Mana; Mohammad Rubayet Hasan; Mohammed Suleiman; Eman Al Maslamani; Omar Imam; Diane Roscoe; Patrick Tang Journal: Microbiol Spectr Date: 2021-11-10
Authors: Lufuno Muleba; Renay Van Wyk; Jennifer Pienaar; Edith Ratshikhopha; Tanusha Singh Journal: Int J Environ Res Public Health Date: 2022-07-28 Impact factor: 4.614
Authors: Stephanie Evans; Emily Agnew; Emilia Vynnycky; James Stimson; Alex Bhattacharya; Christopher Rooney; Ben Warne; Julie Robotham Journal: Philos Trans R Soc Lond B Biol Sci Date: 2021-05-31 Impact factor: 6.237
Authors: George Cholankeril; Karthik Goli; Abbas Rana; Ruben Hernaez; Alexander Podboy; Prasun Jalal; Ben L Da; Sanjaya K Satapathy; Donghee Kim; Aijaz Ahmed; John Goss; Fasiha Kanwal Journal: Hepatology Date: 2021-09-28 Impact factor: 17.298